Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

PRLDPRLD
Showing 8 of 23 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in PRELUDE THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 841,862 shares of PRLD (PRELUDE THERAPEUTICS INC), worth $4.5M as of 2026-Q2. The position was increased (+178.3% shares). PRLD represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$4.5M

Current Shares

841,862

Total Value Change

+$3.7M

Total Shares Change

+450,146

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
841,862
+178.3%
$4.5M0.0%$5.33
43
2026-Q1
Increased
302,458
+10.8%
$1M0.0%$2.63
28
2025-Q4
Increased
272,886
+25.4%
$791,5020.0%$2.84
21
2025-Q3
Unchanged
217,568
0.0%
$313,3660.0%$1.37
0
2025-Q2
Decreased
217,568
-46.3%
$176,1350.0%$0.79
0
2025-Q1
Increased
404,955
+0.7%
$311,0460.0%$0.80
16
2024-Q4
Increased
402,336
+2.7%
$513,0460.0%$1.21
17
2024-Q3
Increased
391,716
+8.2%
$810,9410.0%$2.12
27

Other major holders of PRLD: BAKER BROS. ADVISORS LP, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used